Purchase Order W81K0023P0260
- Not listed
- Agilent Technologies Inc. was awarded a purchase order contract on October 1, 2024, by the Defense Health Agency to supply Agilent reagents for use with government-owned Agilent Artisan Link equipment. This firm fixed-price contract has a ceiling value of $641,106.81 and extends through September 30, 2029, with performance taking place in Carpinteria, California. The contract was awarded without a set-aside designation through an unrestricted solicitation that employed a Lowest Price Technically...
- The Defense Health Agency awarded a $913,640.40 firm fixed-price purchase order to Agilent Technologies Inc. on September 1, 2025, for the delivery and support of a fully automated immunohistochemistry staining system at Fort Liberty, North Carolina. The contract, which extends through August 31, 2030, encompasses the provision of IHC staining equipment, reagents, comprehensive training, and ongoing maintenance services. The requirement originated from a competitive solicitation issued by the...
- Agilent Technologies Inc., through its Customer Service and Sales Division, was awarded a definitive firm fixed-price contract by Veterans Integrated Service Network 5 (VISN 5) on November 1, 2025, to supply immunohistochemistry analyzer tests for the Washington DC VA Medical Center. The five-year contract has a ceiling value of $750,000 and extends through October 31, 2030. This award was made without a set-aside designation through full and open competition, reflecting Agilent's established...
- This federal contract award to Agilent Technologies Inc. is for the delivery of Envision FLEX Kits, which are immunohistochemistry (IHC) products used on the government-owned Autostainer Link system. The contract, valued at $195,000.00, was awarded by the Defense Health Agency and has an ultimate completion date of September 30, 2023. This is a sole-source, firm-fixed price contract with no set-aside designation. The contract was awarded under a Special Notice, rather than a competitive...
- Agilent Technologies Inc. Customer Service and Sales Division was awarded a firm fixed price purchase order by the Defense Health Agency for $35,169.88 to deliver tissue stainer reagents. The award was made on October 1, 2023 to fulfill a solicitation posted on August 29, 2023 by the agency. The original solicitation sought reagents for use with a government-owned Dako Artisan Link Special Staining System. No set-aside designation was applied to this procurement. As the prime contractor, Agilent...
- This $249,780.40 firm fixed-price purchase order was awarded by the Defense Health Agency to Agilent Technologies Inc., a for-profit manufacturer of analytical instruments, software, services, consumables, and reagents. The contract is for the delivery of cancer testing supplies, including reagents, to support laboratory operations and cancer diagnosis at Defense Health Agency facilities. Agilent Technologies is the prime contractor and has previously provided medical equipment, maintenance, and...
- Agilent Technologies Inc., through its Customer Service and Sales Division, was awarded a $19,850.40 firm fixed-price purchase order by the Defense Health Agency on August 1, 2024, for an AUTOSTAINER LINK 48 service plan. The contract, which is not set-aside designated, will be performed in Colorado Springs, Colorado, with an ultimate completion date of July 31, 2026. The AUTOSTAINER LINK 48 is an automated staining system used in clinical and research laboratories for immunohistochemistry and...
- Agilent Technologies Inc. was awarded a purchase order valued at $10,220.00 by the Bureau of Medicine and Surgery (a Defense agency) on August 29, 2022, for a high sensitivity DNA chip. This firm fixed-price contract, which is not set-aside designated, indicates full and open competition and must be completed by November 30, 2022. The contract is being performed in Peru and represents a child contract under Agilent Technologies, Inc. headquarters division, reflecting the company's established...
- This federal contract award was issued by the U.S. government to Agilent Technologies, Inc., a leading provider of analytical instruments, software, services, and consumables for laboratory use. The $94,203.00 firm fixed price delivery order contract is for supplies, with no set-aside designation. The contract has an ultimate completion date of June 25, 2008 and was awarded on that same date. Agilent Technologies, Inc. is the prime contractor, and no major subcontractors are mentioned. The...
- This federal contract award, valued at $46,648.22, was issued by the Defense Health Agency to Agilent Technologies Inc. for the procurement of laboratory reagents. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing a range of analytical instruments, software, services, and consumables to federal agencies. The company has a strong track...
Agilent Technologies Inc., headquartered in Santa Clara, California, was awarded a $177,264.35 firm fixed-price purchase order by the Defense Health Agency on October 1, 2023, for base reagents and supplies related to immunohistochemistry (IHC). The contract, which extends through September 30, 2026, will be performed at Agilent's facility in Marshallton, Delaware. This award was issued without a set-aside designation, reflecting full and open competition in the federal marketplace. The purchase order originated from a special notice solicitation posted on August 17, 2023, with a one-day response window. This contract aligns with Agilent's established federal portfolio, which emphasizes the provision of specialized laboratory reagents, analytical instruments, and consumables to defense and civilian agencies. The Defense Health Agency procures these materials to support medical research, diagnostic testing, and clinical operations across the Department of Defense healthcare system. Agilent's deep expertise in immunohistochemistry staining systems and reagents—demonstrated through existing indefinite delivery contracts with the Department of Veterans Affairs valued at $325,000 and the U.S. Army Research, Development and Engineering Command valued at $14.3 million—positions the company as a critical supplier of high-quality scientific consumables for federal healthcare and research missions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Reagents & Supplies for Envision FLEX pH detection | W81K00-23-Q-0187 | Department of the Army Medical Command | Special Notice 1/1 | 8/17/23, 8:53 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $0 | 8/21/25 | |
| P00003 | Funding Only Action | $60.4k | 11/6/24 | |
| P00002 | Exercise an Option | $0 | 9/9/24 | |
| P00001 | Funding Only Action | $52.0k | 11/1/23 | |
| Not listed | Not listed | $0 | 9/12/23 |